Science Corporation 为首例 Stargardt 病患者植入 PRIMA 视力芯片
原标题：Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
AI 摘要
Science Corporation 宣布其视力恢复芯片 PRIMA 已植入首例 Stargardt 病患者体内，该患者于 5 月在澳大利亚悉尼眼科医院接受手术，并在康复训练中看到字母、读出单词。公司 CEO Max Hodak 在 TechCrunch Disrupt 上表示，视网膜属于中枢神经系统，PRIMA 是其脑机接口（BCI）布局的一部分，该设备已在欧洲获批用于地理萎缩患者。公司计划明年推出下一代植入体，并在五年内接近原生视力水平。
正文节选
Science Corporation CEO Max Hodak announced that the company has implanted its vision-restoring chip, PRIMA, into its first patient with Stargardt disease, an inherited eye disease that gradually destroys central vision. Hodak, the former president and co-founder of Neuralink, the brain implant company, explained on stage at TechCrunch Disrupt how the company’s work with PRIMA fits into its broader pursuit of a novel brain-computer interface (BCI). “The retina is part of the central nervous syst